An analysis of AI-powered devices that received FDA's "breakthrough" label shows a preference for big-picture, multi-problem ...
Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.
Makower is the Yock family professor of medicine and bioengineering at the Stanford Schools of Medicine and Engineering, and the Byers family director and co-founder of the Stanford Mussallem Center ...
2 日on MSN
Scientists engineer tobacco plant to produce 5 psychedelic compounds in medical breakthrough
Researchers bio-engineered a tobacco plant to produce five key psychedelic compounds for therapeutic use.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する